Latest News- Epigenetics Market: Oncology is expected to lead the Application segment during 2024-2028

The Epigenetics Market is being driven by Rising epigenetic applications in non-oncology diseases

The Epigenetics Market is expected to grow at a CAGR of 14.75% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1477.78 million. The epigenetics market is experiencing significant growth in the life sciences sector, driven by the rising prevalence of chronic diseases and the demand for personalized medicine. Enzyme technology, which involves the production, isolation, purification, and utilization of enzymes in both soluble and immobilized forms for the synthesis of drugs, peptides, and proteins, is a key contributor to this trend. Researchers are engineering enzymes to enhance their desirable properties, such as kinetic features, thermal stability, solvent compatibility, and reaction/substrate specificity, to better understand gene expression. This technology is also utilized in the pharmaceutical industry to develop drugs for treating conditions like spinal injuries, nerve tissue regeneration, and severe combined immunodeficiency (SCID). 

Get more information on Epigenetics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Application
  • Oncology
  • Non-oncology
• Product
  • Reagents
  • Kits
  • Enzymes and others
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising epigenetic applications in non-oncology diseases
• Increasing prevalence of CVDs
• Rising strategic collaboration among vendors

However, the market also witnesses some limitations, which are as follows:

• Lack of clinical validation on direct-to-consumer genetic tests
• Privacy issues concerning data leakage of genetic information
• Unfavorable reimbursement scenario associated with genetic testing

Benefits of Buying Global Epigenetics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Epigenetics Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Epigenetics, the study of heritable changes in gene expression without alteration of DNA sequence, is gaining significant attention in the medical field due to its potential impact on various health conditions. Epigenetic testing and products are increasingly being used for the diagnosis and treatment of diseases such as autoimmune diseases, cancers including breast and cervical cancer, and chronic diseases caused by external stimuli like cigarette smoke, heavy metals, and pesticides. Epigenetic pathways, particularly DNA methylation, play a crucial role in the development of these conditions. The control of genes through epigenetic modifications has opened new avenues for the diagnosis and treatment of reproductive problems and cognitive function impairments. Epigenetic assays are essential tools for understanding these complex processes and developing new therapeutic interventions.

Market Research Overview

The epigenetics market is a significant segment of the global life sciences tools and services industry, which encompasses companies and products involved in the research, development, and production of various tools and services for pharmaceuticals, biotechnology, and laboratory diagnosis of diseases. This market includes epigenetic testing kits, essential nutrients for epigenetic modifications, and epigenetic products focused on DNA methylation and epigenetic pathways. Technavio, a leading global technology research and consulting firm, estimates the global healthcare market size by considering the revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The epigenetics market specifically focuses on autoimmune diseases, cancers, and other health conditions influenced by epigenetic modifications, such as monocytes and genome sequencing.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/